3 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 3 |
Follow Antimicrobial Susceptibility Testing: new trials by email Literature Review of Antimicrobial Susceptibility Testing trials Research Report on Antimicrobial Susceptibility Testing
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication. two sensitive antibiotics(amoxicillin, clarithromycin, metronidazole, tinidazole, levofloxacin, furazolidone and tetracycline), two antibiotics based on personal medication history(amoxicillin,clarithromycin,furazolidone), one proton pump inhibitor(PPI) - Helicobacter Pylori Infection, Antimicrobial Susceptibility Testing | Phase 4 | Unknown | Shandong University | 400 | 2018-07-01 | 2018-06-27 |
| Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment amoxicillin, clarithromycin, tinidazole - Antimicrobial Susceptibility Testing, Triple Therapy | Phase 4 | Unknown | Yanqing Li | 120 | 2017-05-30 | 2017-05-03 |
| Antimicrobial Susceptibility Testing Guided Antibiotic Selection Strategies in Salvage Helicobacter Pylori Treatment Clarithromycin susceptibility dependant strategy, 2 susceptible antibiotics (amoxicillin, clarithromycin, metronidazole, tinidazole,levofloxacin, furazolidone and tetracycline ), proton pump inhibitor (PPI) and Colloidal Bismuth Pectin - Helicobacter Pylori Infection, Antimicrobial Susceptibility Testing | Phase 4 | Unknown | Shandong University | 480 | 2017-04-20 | 2017-04-25 |
Clarithromycin (3) · Furazolidone (3) · Levofloxacin (3) · Tetracycline (3) · Tinidazole (3) · Amoxicillin (2) · Metronidazole (2) · Proton Pump Inhibitors (1) · ilaprazole (1)
Shandong University (2) · Yanqing Li (1)
China (2)
Li Yanqing, MD, PhD (2) · Xiuli Zuo, PhD,MD (1)